Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 2,500 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Immatics NV | IMTXW | NASDAQ | Equity Warrant |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0485 | 19.28% | 0.30 | 15:02:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.2515 | 0.2515 | 0.3325 | 0.30 | 0.2515 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 25 | 2,500 | 0.271125 | 678 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 100 | 0.2515 | USD |
Immatics NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 21.29M | 84.66M | - | 55.14M | -96.99M | -1.15 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Immatics NV
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
IMTXW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Immatics NV is engaged in the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's pipeline consists of two lead product classes, engineered Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics (TCER). Each therapeutic modality has distinct attributes to produce the desired therapeutic effect for patients at different disease stages and with different types of tumors focusing on particularly hard-to-treat solid cancers. |
NASDAQ:IMTXW -
What is the current Immatics NV share price?
The current share price of Immatics NV is US$ 0.30
How many Immatics NV shares are in issue?
Immatics NV has 84,658,000 shares in issue
What is the market cap of Immatics NV?
The market capitalisation of Immatics NV is USD 21.29M
What is the 1 year trading range for Immatics NV share price?
Immatics NV has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Immatics NV?
The price to earnings ratio of Immatics NV is -6.47
What is the cash to sales ratio of Immatics NV?
The cash to sales ratio of Immatics NV is 11.38
What is the reporting currency for Immatics NV?
Immatics NV reports financial results in EUR
What is the latest annual turnover for Immatics NV?
The latest annual turnover of Immatics NV is EUR 55.14M
What is the latest annual profit for Immatics NV?
The latest annual profit of Immatics NV is EUR -96.99M
What is the registered address of Immatics NV?
The registered address for Immatics NV is PAUL-EHRLICH-STREET 15, TUBINGEN, 72076
What is the Immatics NV website address?
The website address for Immatics NV is www.immatics.com
Which industry sector does Immatics NV operate in?
Immatics NV operates in the HEALTH & ALLIED SERVICES,NEC sector
